Integrated Research (IRI) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
12 Jan, 2026Opening remarks and agenda
Meeting opened with acknowledgment of traditional land owners, confirmation of quorum, and welcoming of shareholders, guests, and auditors both in person and online.
Chair Peter Lloyd and CEO Ian Lowe delivered addresses outlining the meeting's focus on financial performance, strategy, and governance.
Voting and Q&A procedures explained, with all resolutions to be decided by poll for transparency.
Financial performance review
FY24 saw a 22% increase in total contract value to AUD 83.9 million and a 19% rise in group revenues to AUD 83.3 million, driven by renewals and growth in the Americas.
Net profit after tax rose to AUD 27.1 million, reversing a prior year loss, with NPAT up 963% year-on-year, excluding prior impairments.
Cash reserves increased by 72% to AUD 31.9 million, supporting future growth initiatives.
Americas revenue grew 39%, while Europe declined 25-28% and Asia-Pacific dropped 8%.
Proforma revenue was stable at $74.8M, with EBITDA margin at 22% and cash conversion rate at 97%.
Board and executive committee updates
Ian Lowe appointed CEO and Managing Director effective October 1, 2024, with board composition reduced to four non-executive directors.
Board refresh included new, growth-oriented appointments and gratitude expressed to outgoing directors.
Latest events from Integrated Research
- AI-driven innovation and hybrid pricing fuel growth and expand market reach.IRI
Investor Day 202624 Mar 2026 - Revenue and profit down, but strong cash and new AI products support product-led growth.IRI
H1 202626 Feb 2026 - Product-led growth and AI innovation drive future focus amid short-term profit decline.IRI
AGM 20253 Feb 2026 - Statutory revenue up 19%, net cash up 72%, with FY25 focused on product-led growth.IRI
H2 202423 Jan 2026 - New business revenue surged 76% year-over-year, offsetting weaker renewals and profit declines.IRI
H1 20253 Dec 2025 - Profits fell as investment in product-led growth and AI accelerates, targeting future growth.IRI
H2 202524 Nov 2025 - New business TCV surges 87% as IR pivots to product-led growth despite overall revenue decline.IRI
Trading Update13 Jun 2025 - Strong FY24 results and CEO transition set the stage for product-led growth.IRI
Trading Update13 Jun 2025 - New business TCV jumps 77% as EBITDA beats guidance and cash remains stable.IRI
Trading Update6 Jun 2025